Evidence map›Paper›PMID 34704040›Full record

ReviewRSC chemical biology2021

Caroline R Buchholz, William C K Pomerantz

Abstract readReview
In one paragraph

Review in RSC chemical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Characterization of a CYP107 family vitamin DArchives of biochemistry and biophysics · 2026
    Article
  2. Synthesis and In Vivo Incorporation of 4-Difluoromethyl-L-Phenylalanine Into Proteins.Chembiochem : a European journal of chemical biology · 2026
    Article
  3. Decoding Galectin-Glycan Recognition withJournal of the American Chemical Society · 2026
    Article
  4. Slowly exchanging bound states of SARS-CoV-2 3CLStructural dynamics (Melville, N.Y.) · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. The Evolving Landscape of NMR Structural Elucidation.Molecules (Basel, Switzerland) · 2026
    Review
  9. EstablishingAnalytical chemistry · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Halogen bonds between ligands and proteins: Can we use them in validation?Protein science : a publication of the Protein Society · 2025
    Article
  14. Article
  15. Review
  16. Target Engagement Assays in Early Drug Discovery.Journal of medicinal chemistry · 2025
    Review
  17. Leveraging relaxation-optimizedNature chemistry · 2025
    Article
  18. Rational design ofNature communications · 2025
    Article
  19. Article
  20. Fragment-based drug discovery: A graphical review.Current research in pharmacology and drug discovery · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Caroline R BuchholzDepartment of Medicinal Chemistry, University of Minnesota 308 Harvard Street SE Minneapolis Minnesota 55455 USA wcp@umn.edu.
William C K PomerantzDepartment of Medicinal Chemistry, University of Minnesota 308 Harvard Street SE Minneapolis Minnesota 55455 USA wcp@umn.edu.ORCID https://orcid.org/0000-0002-0163-4078

Funding

Training the Next Generation of Chemical BiologistsT32GM132029 · NIGMS · UNIVERSITY OF MINNESOTA · PI Erin Elizabeth Carlson, William Charles Krause Pomerantz · 2019 to 2026
$2.7M
Chemical Probe Development for Epigenetic Complexes Enabled by Protein-Observed 19F NMRR35GM140837 · NIGMS · UNIVERSITY OF MINNESOTA · PI William Charles Krause Pomerantz · 2021 to 2026
$2.5M
NIGMS NIH HHS R35 GM140837NIGMS NIH HHS T32 GM132029
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34704040
PMCPMC8496043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.